Healthcare organizations investing in AI are watching Anthropic’s recent policy decisions with more than passing interest. The company has relaxed internal safety standards on one front while losing defense contracts for holding firm on another. These moves raise a question that matters to clinical and administrative leaders alike: what stable, trustworthy policy posture can be expected from commercial AI firms operating under real-world constraints?Anthropic finds itself at the center of two co...
Continue Reading
Sign up for FREE to read the full article and access 150K+ alternative investment headlines.
Alternative Investment News